Genetic Signatures Ltd
ASX:GSS

Watchlist Manager
Genetic Signatures Ltd Logo
Genetic Signatures Ltd
ASX:GSS
Watchlist
Price: 0.26 AUD Market Closed
Market Cap: 59.1m AUD

Wall Street
Price Targets

GSS Price Targets Summary
Genetic Signatures Ltd

Wall Street analysts forecast GSS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSS is 0.56 AUD with a low forecast of 0.56 AUD and a high forecast of 0.58 AUD.

Lowest
Price Target
0.56 AUD
114% Upside
Average
Price Target
0.56 AUD
116% Upside
Highest
Price Target
0.58 AUD
122% Upside
Genetic Signatures Ltd Competitors:
Price Targets
LONN
Lonza Group AG
33% Upside
WST
West Pharmaceutical Services Inc
31% Upside
A
Agilent Technologies Inc
22% Upside
GENO
Genovis AB
76% Upside
688114
MGI Tech Co Ltd
29% Upside
688315
Novogene Co Ltd
20% Upside
CTKB
Cytek Biosciences Inc
21% Upside
SFZN
Siegfried Holding AG
54% Upside

Revenue
Forecast

Revenue Estimate
Genetic Signatures Ltd

For the last 12 years the compound annual growth rate for Genetic Signatures Ltd's revenue is 44%. The projected CAGR for the next 3 years is 30%.

44%
Past Growth
30%
Estimated Growth
Estimates Accuracy
18%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Genetic Signatures Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Genetic Signatures Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GSS's stock price target?
Price Target
0.56 AUD

According to Wall Street analysts, the average 1-year price target for GSS is 0.56 AUD with a low forecast of 0.56 AUD and a high forecast of 0.58 AUD.

What is Genetic Signatures Ltd's Revenue forecast?
Projected CAGR
30%

For the last 12 years the compound annual growth rate for Genetic Signatures Ltd's revenue is 44%. The projected CAGR for the next 3 years is 30%.

Back to Top